MDA SPACE LTD (MDA.CA) Stock Fundamental Analysis
Canada - TSX:MDA - CA55293N1096 - Common Stock
22.26 CAD
+0.83 (+3.87%)
Taking everything into account, MDA scores 6 out of 10 in our fundamental rating. MDA was compared to 11 industry peers in the Aerospace & Defense industry. MDA scores excellent on profitability, but there are some minor concerns on its financial health. An interesting combination arises when we look at growth and value: MDA is growing strongly while it also seems undervalued. With these ratings, MDA could be worth investigating further for value and growth investing!.
1. Profitability
1.1 Basic Checks
In the past year MDA was profitable.
MDA had a positive operating cash flow in the past year.
Of the past 5 years MDA 4 years were profitable.
Each year in the past 5 years MDA had a positive operating cash flow.
1.2 Ratios
The Return On Assets of MDA (3.63%) is better than 90.91% of its industry peers.
The Return On Equity of MDA (8.94%) is better than 100.00% of its industry peers.
The Return On Invested Capital of MDA (5.72%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for MDA is below the industry average of 8.31%.
The 3 year average ROIC (3.99%) for MDA is below the current ROIC(5.72%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.63% | ||
| ROE | 8.94% | ||
| ROIC | 5.72% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
1.3 Margins
With an excellent Profit Margin value of 8.48%, MDA belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
MDA's Profit Margin has improved in the last couple of years.
MDA has a Operating Margin (10.97%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of MDA has grown nicely.
MDA has a better Gross Margin (24.54%) than 72.73% of its industry peers.
MDA's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.97% | ||
| PM (TTM) | 8.48% | ||
| GM | 24.54% |
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MDA is destroying value.
Compared to 1 year ago, MDA has more shares outstanding
Compared to 1 year ago, MDA has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.50, we must say that MDA is in the distress zone and has some risk of bankruptcy.
With an excellent Altman-Z score value of 1.50, MDA belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
MDA has a debt to FCF ratio of 0.55. This is a very positive value and a sign of high solvency as it would only need 0.55 years to pay back of all of its debts.
MDA's Debt to FCF ratio of 0.55 is amongst the best of the industry. MDA outperforms 100.00% of its industry peers.
MDA has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.29, MDA belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.29 | ||
| Debt/FCF | 0.55 | ||
| Altman-Z | 1.5 |
ROIC/WACC0.63
WACC9.04%
2.3 Liquidity
A Current Ratio of 0.86 indicates that MDA may have some problems paying its short term obligations.
The Current ratio of MDA (0.86) is worse than 72.73% of its industry peers.
MDA has a Quick Ratio of 0.86. This is a bad value and indicates that MDA is not financially healthy enough and could expect problems in meeting its short term obligations.
With a decent Quick ratio value of 0.85, MDA is doing good in the industry, outperforming 72.73% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.86 | ||
| Quick Ratio | 0.85 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 185.37% over the past year.
MDA shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 185.75% yearly.
Looking at the last year, MDA shows a very strong growth in Revenue. The Revenue has grown by 57.21%.
Measured over the past years, MDA shows a very strong growth in Revenue. The Revenue has been growing by 31.32% on average per year.
EPS 1Y (TTM)185.37%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%322.22%
Revenue 1Y (TTM)57.21%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%54.26%
3.2 Future
MDA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 34.67% yearly.
Based on estimates for the next years, MDA will show a very strong growth in Revenue. The Revenue will grow by 23.76% on average per year.
EPS Next Y107.77%
EPS Next 2Y49.97%
EPS Next 3Y34.67%
EPS Next 5YN/A
Revenue Next Year52.07%
Revenue Next 2Y31.15%
Revenue Next 3Y23.76%
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
MDA is valuated rather expensively with a Price/Earnings ratio of 19.03.
Compared to the rest of the industry, the Price/Earnings ratio of MDA indicates a somewhat cheap valuation: MDA is cheaper than 72.73% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.89, MDA is valued a bit cheaper.
The Price/Forward Earnings ratio is 14.14, which indicates a correct valuation of MDA.
Based on the Price/Forward Earnings ratio, MDA is valued a bit cheaper than 72.73% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 34.59. MDA is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.03 | ||
| Fwd PE | 14.14 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, MDA is valued a bit cheaper than 63.64% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, MDA is valued a bit cheaper than 72.73% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.96 | ||
| EV/EBITDA | 10.33 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MDA has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as MDA's earnings are expected to grow with 34.67% in the coming years.
PEG (NY)0.18
PEG (5Y)N/A
EPS Next 2Y49.97%
EPS Next 3Y34.67%
5. Dividend
5.1 Amount
No dividends for MDA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:MDA (11/14/2025, 7:00:00 PM)
22.26
+0.83 (+3.87%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners32.56%
Inst Owner ChangeN/A
Ins Owners1.18%
Ins Owner ChangeN/A
Market Cap2.81B
Revenue(TTM)1.35B
Net Income(TTM)114.70M
Analysts78.33
Price Target44.43 (99.6%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.62%
Min EPS beat(2)21.08%
Max EPS beat(2)22.16%
EPS beat(4)4
Avg EPS beat(4)29.79%
Min EPS beat(4)19.18%
Max EPS beat(4)56.74%
EPS beat(8)7
Avg EPS beat(8)31.88%
EPS beat(12)11
Avg EPS beat(12)88.39%
EPS beat(16)14
Avg EPS beat(16)87.43%
Revenue beat(2)1
Avg Revenue beat(2)3.32%
Min Revenue beat(2)-0.24%
Max Revenue beat(2)6.87%
Revenue beat(4)3
Avg Revenue beat(4)3.78%
Min Revenue beat(4)-0.24%
Max Revenue beat(4)7.65%
Revenue beat(8)5
Avg Revenue beat(8)3.09%
Revenue beat(12)9
Avg Revenue beat(12)2.82%
Revenue beat(16)10
Avg Revenue beat(16)0.84%
PT rev (1m)1.48%
PT rev (3m)-10.31%
EPS NQ rev (1m)-0.99%
EPS NQ rev (3m)-6.83%
EPS NY rev (1m)-1.23%
EPS NY rev (3m)22.24%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.09%
Revenue NY rev (1m)-0.12%
Revenue NY rev (3m)-0.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.03 | ||
| Fwd PE | 14.14 | ||
| P/S | 2.07 | ||
| P/FCF | 3.96 | ||
| P/OCF | 2.92 | ||
| P/B | 2.19 | ||
| P/tB | 11.05 | ||
| EV/EBITDA | 10.33 |
EPS(TTM)1.17
EY5.26%
EPS(NY)1.57
Fwd EY7.07%
FCF(TTM)5.62
FCFY25.24%
OCF(TTM)7.63
OCFY34.27%
SpS10.73
BVpS10.17
TBVpS2.01
PEG (NY)0.18
PEG (5Y)N/A
Graham Number16.36
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.63% | ||
| ROE | 8.94% | ||
| ROCE | 7.95% | ||
| ROIC | 5.72% | ||
| ROICexc | 8.9% | ||
| ROICexgc | 61.78% | ||
| OM | 10.97% | ||
| PM (TTM) | 8.48% | ||
| GM | 24.54% | ||
| FCFM | 52.35% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
ROICexc(3y)4.25%
ROICexc(5y)N/A
ROICexgc(3y)14.8%
ROICexgc(5y)N/A
ROCE(3y)5.54%
ROCE(5y)N/A
ROICexgc growth 3Y59.28%
ROICexgc growth 5YN/A
ROICexc growth 3Y71.38%
ROICexc growth 5YN/A
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
F-Score6
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.29 | ||
| Debt/FCF | 0.55 | ||
| Debt/EBITDA | 1.52 | ||
| Cap/Depr | 262.11% | ||
| Cap/Sales | 18.71% | ||
| Interest Coverage | 8.48 | ||
| Cash Conversion | 392.53% | ||
| Profit Quality | 617.7% | ||
| Current Ratio | 0.86 | ||
| Quick Ratio | 0.85 | ||
| Altman-Z | 1.5 |
F-Score6
WACC9.04%
ROIC/WACC0.63
Cap/Depr(3y)234.8%
Cap/Depr(5y)169.15%
Cap/Sales(3y)23.53%
Cap/Sales(5y)18.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)185.37%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%322.22%
EPS Next Y107.77%
EPS Next 2Y49.97%
EPS Next 3Y34.67%
EPS Next 5YN/A
Revenue 1Y (TTM)57.21%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%54.26%
Revenue Next Year52.07%
Revenue Next 2Y31.15%
Revenue Next 3Y23.76%
Revenue Next 5YN/A
EBIT growth 1Y115.07%
EBIT growth 3Y76.57%
EBIT growth 5YN/A
EBIT Next Year179.33%
EBIT Next 3Y51.75%
EBIT Next 5YN/A
FCF growth 1Y1778.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y628.56%
OCF growth 3Y124.48%
OCF growth 5YN/A
MDA SPACE LTD / MDA.CA FAQ
What is the fundamental rating for MDA stock?
ChartMill assigns a fundamental rating of 6 / 10 to MDA.CA.
What is the valuation status for MDA stock?
ChartMill assigns a valuation rating of 7 / 10 to MDA SPACE LTD (MDA.CA). This can be considered as Undervalued.
What is the profitability of MDA stock?
MDA SPACE LTD (MDA.CA) has a profitability rating of 7 / 10.
What is the valuation of MDA SPACE LTD based on its PE and PB ratios?
The Price/Earnings (PE) ratio for MDA SPACE LTD (MDA.CA) is 19.03 and the Price/Book (PB) ratio is 2.19.